Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer.
- DOI
- 10.1002/pros.10130
- Published
- 2002 Oct 1
- Container
- The Prostate
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/pros.10130,
title = {Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer.},
author = {Gulley J and Chen AP and Dahut W and Arlen PM and Bastian A and Steinberg SM and Tsang K and Panicali D and Poole D and Schlom J and Michael Hamilton J},
year = {2002},
journal = {The Prostate},
doi = {10.1002/pros.10130},
url = {https://doi.org/10.1002/pros.10130}
}RIS
TY - JOUR TI - Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer. AU - Gulley J AU - Chen AP AU - Dahut W AU - Arlen PM AU - Bastian A AU - Steinberg SM AU - Tsang K AU - Panicali D AU - Poole D AU - Schlom J AU - Michael Hamilton J PY - 2002 JO - The Prostate DO - 10.1002/pros.10130 UR - https://doi.org/10.1002/pros.10130 ER -
APA
J, G., AP, C., W, D., PM, A., A, B., SM, S., K, T., D, P., D, P., J, S., & J, M. H. (2002). Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer.. The Prostate. https://doi.org/10.1002/pros.10130
Source records
- pubmed · retrieved 2026-09-25T04:25:13.421Z
- europe-pmc · retrieved 2026-09-25T04:25:13.469Z